Last reviewed · How we verify
NCT04071860
Developing a Non-contact Sleep Apnoea Detector, Suitable for Home Studies- The Safescan Study
trial in Sleep Apnoea in 445 participants. Completed in 31 July 2021.
20 December 2019
Quick facts
| Lead sponsor | Papworth Hospital NHS Foundation Trust |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 445 |
| Start date | 9 January 2019 |
| Primary completion | 20 December 2019 |
| Estimated completion | 31 July 2021 |
| Sites | 1 location across United Kingdom |
Conditions studied
- Sleep Apnoea — all drugs for Sleep Apnoea →
- Obstructive Sleep Apnoea — all drugs for Obstructive Sleep Apnoea →
Sponsor
Papworth Hospital NHS Foundation Trust
Who can join
18 and older, any sex, with Sleep Apnoea or Obstructive Sleep Apnoea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Sleep apnoea (SA) is a common condition in adults and children that causes disturbed sleep and daytime symptoms. It is characterised by disrupted breathing with disturbed sleep patterns. In adults this can lead to dangerous daytime sleepiness affecting for example driving performance. In children it may lead to hyperactivity in the day and poor school performance. There are a number of techniques for diagnosing the disorder but they can affect the quality of sleep which sometimes makes them inaccurate. Most are unsuitable for small children who cannot understand the value of the tests and tend to remove the monitoring wires and devices in the night. This study aims to validate a new non contact device "Safescan", based on low power radar technology, which can be put under a bed and record breathing patterns with no measuring device in contact with the sleeper. In this initial study the device will be validated in adults, against the gold standard of polysomnography (PSG) in the sleep laboratory at Royal Papworth Hospital.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04071860
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Papworth Hospital NHS Foundation Trust trials
Trials by the same sponsor.
- NCT07289100 — Novel Sensors and Artificial Intelligence for Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis and Bronchie · recruiting
- NCT06433960 — Radial Artery Assessment in Surgical Coronary Revascularisation · completed
- NCT05775263 — Validation of UK Protocols to Exclude Brain Blood Flow During Normothermic Regional Perfusion (NRP) · unknown
- NCT06421792 — PrOtamIne doSing clOt imagiNg (POISON) Study · not yet recruiting
- NCT06072872 — Portable Continuous Positive Airways Pressure (CPAP) in Excessive Central Airway Collapse (ECAC) Study · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04071860 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Papworth Hospital NHS Foundation Trust
- Last refreshed: 28 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04071860.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing